Higher dose alglucosidase alfa is associated with improved overall survival in infantile-onset Pompe disease (IOPD): data from the Pompe Registry

被引：0
|
作者：
Priya S. Kishnani
David Kronn
Shugo Suwazono
Alexander Broomfield
Juan Llerena
Zuhair Nasser Al-Hassnan
Julie L. Batista
Kathryn M. Wilson
Magali Periquet
Nadia Daba
Andreas Hahn
Yin-Hsiu Chien
机构：
[1] Duke University Medical Center,Division of Medical Genetics, Department of Pediatrics
[2] New York Medical College,Department of Pathology and Pediatrics
[3] National Hospital Organization Okinawa National Hospital,Center for Clinical Neuroscience
[4] Central Manchester Foundation Trust,Willink Biochemical Genetics Unit, Manchester Center for Genomic Medicine, St Mary’s Hospital
[5] Instituto Fernandes Figueira/FIOCRUZ,Centro de Genética Médica
[6] King Faisal Specialist Hospital and Research Center,Department of Medical Genomics, Center for Genomic Medicine
[7] Sanofi,Department of Child Neurology
[8] Navitas Data Sciences,Department of Medical Genetics and Pediatrics
[9] Sanofi,undefined
[10] Sanofi,undefined
[11] University Hospital Giessen,undefined
[12] National Taiwan University Hospital,undefined
来源：
Orphanet Journal of Rare Diseases | / 18卷
关键词：
Alglucosidase alfa; Dose; Enzyme replacement therapy; Infantile onset Pompe disease; Pompe disease; Pompe registry;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 35 条
  • [1] Higher dose alglucosidase alfa is associated with improved overall survival in infantile-onset Pompe disease (IOPD): data from the Pompe Registry
    Kishnani, Priya S.
    Kronn, David
    Suwazono, Shugo
    Broomfield, Alexander
    Llerena, Juan
    Al-Hassnan, Zuhair Nasser
    Batista, Julie L.
    Wilson, Kathryn M.
    Periquet, Magali
    Daba, Nadia
    Hahn, Andreas
    Chien, Yin-Hsiu
    ORPHANET JOURNAL OF RARE DISEASES, 2023, 18 (01)
  • [2] Desensitization of two young patients with infantile-onset Pompe disease and severe reactions to alglucosidase alfa
    V. Gragnaniello
    S. Fecarotta
    A. Pecoraro
    A. Tarallo
    A. Catzola
    G. Spadaro
    G. Parenti
    R. Della Casa
    Neurological Sciences, 2019, 40 : 1453 - 1455
  • [3] Desensitization of two young patients with infantile-onset Pompe disease and severe reactions to alglucosidase alfa
    Gragnaniello, V.
    Fecarotta, S.
    Pecoraro, A.
    Tarallo, A.
    Catzola, A.
    Spadaro, G.
    Parenti, G.
    Della Casa, R.
    NEUROLOGICAL SCIENCES, 2019, 40 (07) : 1453 - 1455
  • [4] Efficacy of transitioning from alglucosidase alfa to avalglucosidase alfa in infantile-onset Pompe disease: A single-center cohort analysis
    Chien, Yin-Hsuan
    Chen, Hui-An
    Hsu, Rai-Hseng
    Yeh, Chien-Hua
    Fang, Ching-Ya
    Lee, Ni-Chung
    Hwu, Wuh-Liang
    Chien, Yin-Hsiu
    GENETICS IN MEDICINE, 2025, 27 (05)
  • [5] A Multi-Centre Prospective Study of the Efficacy and Safety of Alglucosidase Alfa in Chinese Patients With Infantile-Onset Pompe Disease
    Zhu, Diqi
    Zhu, Jiacong
    Qiu, Wenjuan
    Wang, Benzhen
    Liu, Lin
    Yu, Xiaodan
    Ou, Zhenheng
    Shan, Guangsong
    Wang, Jian
    Li, Bin
    Chen, Xiaokang
    Liu, Cong
    Li, Zipu
    Fu, Lijun
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [6] Efficacy and safety of enzyme replacement therapy with alglucosidase alfa for the treatment of patients with infantile-onset Pompe disease: a systematic review and metanalysis
    Dornelles, A. D.
    Junges, A. P. P.
    Krug, B.
    Goncalves, C.
    de Oliveira Junior, H. A.
    Schwartz, I. V. D.
    FRONTIERS IN PEDIATRICS, 2024, 12
  • [7] Earlier and higher dosing of alglucosidase alfa improve outcomes in patients with infantile -onset Pompe disease: Evidence from real -world experiences
    Chien, Yin-Hsiu
    Tsai, Wen-Hui
    Chang, Chaw-Liang
    Chiu, Pao-Chin
    Chou, Yen-Yin
    Tsai, Fuu-Jen
    Wong, Siew-Lee
    Lee, Ni-Chung
    Hwu, Wuh-Liang
    MOLECULAR GENETICS AND METABOLISM REPORTS, 2020, 23
  • [8] Atypical infantile-onset Pompe disease with good prognosis from mainland China: A case report
    Zhang, Ying
    Zhang, Cheng
    Shu, Jian-Bo
    Zhang, Fang
    WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (10) : 3278 - 3283
  • [9] Avalglucosidase alfa in infantile-onset Pompe disease: A snapshot of real-world experience in Italy
    Fiumara, Agata
    Sapuppo, Annamaria
    Gasperini, Serena
    Crescitelli, Viola
    Sacchini, Michele
    Procopio, Elena
    Gragnaniello, Vincenza
    Burlina, Alberto
    MOLECULAR GENETICS AND METABOLISM REPORTS, 2024, 40
  • [10] Long-term benefit of enzyme replacement therapy with alglucosidase alfa in adults with Pompe disease: Prospective analysis from the French Pompe Registry
    Semplicini, Claudio
    De Antonio, Marie
    Taouagh, Nadjib
    Bhin, Anthony
    Bouhour, FranOoise
    Echaniz-Laguna, Andoni
    Magot, Armelle
    Nadaj-Pakleza, Aleksandra
    Orlikowski, David
    Sacconi, Sabrina
    Salort-Campana, Emmanuelle
    Sole, Guilhem
    Tard, Cline
    Zagnoli, Fabien
    Hogrel, Jean-Yves
    Hamroun, Dalil
    Lafort, Pascal
    JOURNAL OF INHERITED METABOLIC DISEASE, 2020, 43 (06) : 1219 - 1231
1234